BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 24 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $89 | -100.0% | 20,263 | -58.1% | 0.01% | -52.0% |
| Q3 2022 | $272,000 | +353.3% | 48,347 | +362.5% | 0.02% | +400.0% |
| Q2 2022 | $60,000 | -71.0% | 10,453 | -58.1% | 0.01% | -76.2% |
| Q4 2021 | $207,000 | -22.5% | 24,977 | -24.2% | 0.02% | -12.5% |
| Q3 2021 | $267,000 | +360.3% | 32,952 | +117.9% | 0.02% | +500.0% |
| Q1 2021 | $58,000 | – | 15,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 1,582,450 | $9,890,312 | 26.01% |
| Rosenberg Matthew Hamilton | 12 | $75 | 0.00% |